Guest Editor(s)
Prof. Dr. Yingying Lin
Email: yylin@sibs.ac.cn
Affiliation: Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Homepage:
Research Interests: glioma, radiotherapy, proton therapy
Dr. Keman Liao
Email: kmliao@yeah.net
Affiliation: Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Homepage:
Research Interests: radiation biology
Dr. Qi Lv
Email: lye3210@sina.vip.com
Affiliation: Department of Medical Imaging, Shanghai Xuhui Central Hospital, Shanghai, China
Homepage:
Research Interests: medical imaging, tumor diagnosis, prognosis
Summary
Tumor occurrence, development, and therapeutic response depend on the comprehensive exploration of the pathology and treatment strategies in the field of tumors, particularly in central nervous system (CNS) tumors. Novel findings of the molecular mechanisms of tumor progression are crucial for understanding the complex mechanisms and identifying new targets for the treatment of tumors.
Additionally, the issue focuses on progress in targeted therapies of tumors, especially in CNS malignancies, which aim to attack tumors based on their genetic and molecular profiles, resulting in more effective and less toxic treatments. Advances in therapeutic strategies will also be considered for their role in improving clinical outcomes. Furthermore, the issue emphasizes emerging biomarkers, which may promote personalized medicine approaches for tumors.
Overall, this compilation will integrate molecular insights of tumors, with particular relevance to CNS tumors, to enhance therapeutic efficacy.
With the launch of this Special Issue, we would like to invite original research and reviews that offer insights into the molecular pathology and targeted therapy of tumors, particularly those related to CNS tumors.
Keywords
central nervous system tumors (CNS tumors), tumor molecular mechanisms, targeted therapy, precision medicine, biomarkers, tumor progression